Business
Menin Inhibitors Drug Market Report 2025: Price, Sales & Clinical Trials Insights 2024-2028 - Kura Oncology & Kyowa Kirin Progress with New Drug Applications
Market opportunities for menin inhibitors include addressing unmet needs in high-risk acute leukemias, exploring indications beyond AML to solid tumors and diabetes, leveraging next-gen design for improved safety, and expanding market access through global partnerships and collaborations.Dublin, Oct. 10, 2025 (GLOBE NEWSWIRE) -- The "Menin Inhibitors Drug Market, Price, Sales & Clinical Trials Insight 2028" report has been added to ResearchAndMarkets.com's offering.Report Findings & Highlights:
About this update from Kyowa Kirin Co., Ltd.
[{"type":"image","alt":"Company Logo","displaySize":"","headline":null,"caption":"Company Logo","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":36,"url":"https://media.zenfs.com/en/globenewswire.com/6a90a26a88cc04ec0d3fe15e0ab1be65"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/g_3H8YP5.WdAX5cBtX03VA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTUwO2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/6a90a26a88cc04ec0d3fe15e0ab1be65","width":300,"height":36}},"lazy":false},{"type":"text","content":"Market opportunities for menin inhibitors include addressing unmet needs in high-risk acute leukemias, exploring indications beyond AML to solid tumors and diabetes, leveraging next-gen design for improved safety, and expanding market access through global partnerships and collaborations.","length":289,"tagName":"p"},{"type":"text","content":"Dublin, Oct. 10, 2025 (GLOBE NEWSWIRE) -- The "Menin Inhibitors Drug Market, Price, Sales & Clinical Trials Insight 2028" report has been added to ResearchAndMarkets.com's offering.Report Findings & Highlights:","length":235,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Global Market Size & Future Market Projection: 2024 Till 2028","length":65,"tagName":"p"}]},{"val":[{"type":"text","content":"Global Menin Inhibitors Drug Market Opportunity: > USD 400 Million","length":69,"tagName":"p"}]},{"val":[{"type":"text","content":"Approved Drug Dosage, Pricing & Sales Insight","length":49,"tagName":"p"}]},{"val":[{"type":"text","content":"Menin Inhibitors Drugs Clinical Trials Insight by Company, Indication & Phase","length":81,"tagName":"p"}]},{"val":[{"type":"text","content":"Number of Menin Inhibitors Drugs in Clinical Trials: > 15 Drugs","length":66,"tagName":"p"}]},{"val":[{"type":"text","content":"Insight on Development Technologies Platforms by Companies","length":58,"tagName":"p"}]},{"val":[{"type":"text","content":"Competitive Landscape","length":21,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":409,"olType":false},{"type":"text","content":"Menin Inhibitors Need & Why This Report?","length":44,"tagName":"p"},{"type":"text","content":"Report presents a detailed analysis on all menin inhibitor candidates across different stages of clinical development. These range from early Phase 1 to late stage trials ...